Feeds › 8-K events
8-K events
Major news companies must report to the SEC: results, deals, leadership changes.
About this data
- What it is
- A Form 8-K is how a public company announces major news between its quarterly reports: earnings, an acquisition, a new CEO, a cybersecurity incident. Each filing lists the numbered items it covers.
- Who files it
- The company, usually within four business days of the event.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Many 8-Ks are routine, so the item description is the place to start. Item 9.01, which only lists attached documents, is hidden unless you ask for it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
8-K items filed per day, last 30 days
All items Earnings results (2.02)
One filing can report several items. Item 9.01, which only lists attached documents, is not counted.
Latest 8-K filings
Showing: ticker IGC
| Filed | Company | Item | Form | Filing |
|---|---|---|---|---|
| Jul 14, 2026 | IGC IGC Pharma, Inc. | 7.01 Regulation FD Disclosure | 8-K | 8-K ↗ |
| Jul 6, 2026 | IGC IGC Pharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Jul 6, 2026 | IGC IGC Pharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 8, 2026 | IGC IGC Pharma, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Jun 8, 2026 | IGC IGC Pharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Apr 20, 2026 | IGC IGC Pharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Apr 20, 2026 | IGC IGC Pharma, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Apr 20, 2026 | IGC IGC Pharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Mar 30, 2026 | IGC IGC Pharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Mar 12, 2026 | IGC IGC Pharma, Inc. | 3.02 Unregistered Sales of Equity Securities | 8-K | 8-K ↗ |
| Mar 12, 2026 | IGC IGC Pharma, Inc. | 2.03 Creation of a Direct Financial Obligation | 8-K | 8-K ↗ |
| Mar 12, 2026 | IGC IGC Pharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 6, 2026 | IGC IGC Pharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jan 2, 2026 | IGC IGC Pharma, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Dec 15, 2025 | IGC IGC Pharma, Inc. | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 8-K | 8-K ↗ |
| Nov 14, 2025 | IGC IGC Pharma, Inc. | 2.01 Completion of Acquisition or Disposition of Assets | 8-K | 8-K ↗ |
| Oct 14, 2025 | IGC IGC Pharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
| Oct 14, 2025 | IGC IGC Pharma, Inc. | 5.07 Submission of Matters to a Vote of Security Holders | 8-K | 8-K ↗ |
| Oct 1, 2025 | IGC IGC Pharma, Inc. | 1.01 Entry into a Material Definitive Agreement | 8-K | 8-K ↗ |
| Jun 17, 2025 | IGC IGC Pharma, Inc. | 8.01 Other Events | 8-K | 8-K ↗ |
20 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:48 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances